Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
COVID-19 prevalence survey update

Manatū Hauora – the Ministry of Health has agreed that the COVID-19 prevalence surveys should not advance in their proposed current format. Aotearoa New Zealand has passed the emergency stage of its COVID-19 response, with the virus endemic in our communities. The results of any COVID-19-focused prevalence survey would be unlikely to meaningfully alter any current public health response as there are only two pandemic-related mandates still in place (the 7-day isolation period and mask use for visitors to healthcare facilities).
COVID-19 infection prevalence and seroprevalence surveys are complex projects involving a number of agencies, stakeholders and external providers. The Ministry accepts it took longer than expected to reach this conclusion, given the challenges of a multi-stakeholder, complex project developed during the health reforms.
Prevalence surveys are expected to be a key tool in any future effective population and public health knowledge surveillance system. Any future survey design will benefit from lessons learned during the COVID-19 prevalence surveys project and, where appropriate, will leverage technologies and ways of working established during the pandemic.